BLANDINA BERNAL-MORALES

Dr. BLANDINA BERNAL-MORALES

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in BioMed Research International
Verified
Journal Article
Open access
JRJuan Francisco Rodríguez-Landa
Juan Francisco Rodríguez-Landa
Jonathan Cueto-EscobedoJonathan Cueto-Escobedo
Jonathan Cueto-Escobedo
APAbraham Puga-Olguín
Abraham Puga-Olguín
Eduardo Rivadeneyra DomínguezEduardo Rivadeneyra Domínguez
Eduardo Rivadeneyra Domínguez
BLANDINA BERNAL-MORALESBLANDINA BERNAL-MORALES
BLANDINA BERNAL-MORALES
ASAndrea Santos-Torres
Andrea Santos-Torres
The phytoestrogen genistein produces anxiolytic-like effects in ovariectomized rats, which highlights its potential therapeutic effect in ameliorating anxiety in surgical menopausal women. However, no studies have directly compared the effects of identical doses of genistein and 17β-estradiol, the main estrogen used in hormone replacement therapy in menopausal women. The present study evaluated the anxiolytic-like effects of identical doses of genistein and 17β-estradiol (0.045, 0.09, and 0.18 mg/kg/7 days, s.c.) in a surgical menopause model in rats in the elevated plus maze and locomotor activity tests at 12 weeks after ovariectomy. Additionally, the participation of estrogen receptor-βin the anxiolytic-like effect of genistein and 17β-estradiol was explored by previous administration of the 5 mg/kg tamoxifen antagonist. Genistein and 17β-estradiol (0.09 and 0.18 mg/kg) similarly reduced anxiety-like behavior in the elevated plus maze and also increased the time spent grooming and rearing, without affecting crossing in locomotor activity test. These effects were blocked by tamoxifen. Present results indicate that the phytoestrogen genistein has a similar behavioral profile as 17β-estradiol in rats at 12 weeks after ovariectomy through action at the estrogen receptor-β. Thus genistein has potential for reducing anxiety-like behavior associated with low concentrations of ovarian hormones, which normally occurs during natural and surgical menopause.

1 January 2019 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
JRJuan Francisco Rodríguez-Landa
Juan Francisco Rodríguez-Landa
FHFabiola Hernández-López
Fabiola Hernández-López
Jonathan Cueto-EscobedoJonathan Cueto-Escobedo
Jonathan Cueto-Escobedo
EHEmma Virginia Herrera-Huerta
Emma Virginia Herrera-Huerta
Eduardo Rivadeneyra DomínguezEduardo Rivadeneyra Domínguez
Eduardo Rivadeneyra Domínguez
ERElizabeth Romero-Avendaño
Elizabeth Romero-Avendaño
The present study investigated the effects of the flavonoid chrysin (5,7-dihydroxyflavone) on anxiety-like behavior in rats in a model of surgical menopause and evaluated the participation of γ-aminobutyric acid-A (GABAA) receptors in these actions. At 12 weeks post-ovariectomy, the effects of different doses of chrysin (0.5, 1, 2, and 4 mg/kg) were evaluated in the elevated plus maze, light/dark test, and locomotor activity test, and comparisons were made with the clinically effective anxiolytic diazepam. The participation of GABAA receptors in the actions of chrysin was explored by pretreating the rats with the noncompetitive GABAA chloride ion channel antagonist picrotoxin (1 mg/kg). The results showed that chrysin (2 and 4 mg/kg) reduced anxiety-like behavior in both the elevated plus maze and light/dark test, and these effects were similar to diazepam. Pretreatment with picrotoxin had no effects on its own but prevented the anxiolytic-like effects of chrysin in both tests. Chrysin also increased rearing and grooming, without significantly altering the number of crossings in the locomotor activity test; these effects were also similar to diazepam. In conclusion, the flavonoid chrysin produced anxiolytic-like effects through actions on GABAA receptors in a model of surgical menopause in rats. These findings support the hypothesis that this flavonoid could be a future natural alternative for ameliorating symptoms of anxiety after surgical menopause in women.

17 December 2017 in BioMed Research International
Verified
Journal Article
Open access
PDF file
BLANDINA BERNAL-MORALESBLANDINA BERNAL-MORALES
BLANDINA BERNAL-MORALES
Jonathan Cueto-EscobedoJonathan Cueto-Escobedo
Jonathan Cueto-Escobedo
GGGabriel Guillén-Ruiz
Gabriel Guillén-Ruiz
JRJuan Francisco Rodríguez-Landa
Juan Francisco Rodríguez-Landa
CCCarlos M. Contreras
Carlos M. Contreras
Fatty acids (C6–C18) found in human amniotic fluid, colostrum, and maternal milk reduce behavioral indicators of experimental anxiety in adult Wistar rats. Unknown, however, is whether the anxiolytic-like effects of fatty acids provide a natural mechanism against anxiety in young offspring. The present study assessed the anxiolytic-like effect of a mixture of lauric acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, oleic acid, elaidic acid, and linoleic acid in Wistar rats on postnatal day 28. Infant rats were subjected to the elevated plus maze, defensive burying test, and locomotor activity test. Diazepam was used as a reference anxiolytic drug. A group that was pretreated with picrotoxin was used to explore the participation ofγ-aminobutyric acid-A (GABAA) receptors in the anxiolytic-like effects. Similar to diazepam, the fatty acid mixture significantly increased the frequency of entries into and time spent on the open arms of the elevated plus maze and decreased burying behavior in the defensive burying test, without producing significant changes in spontaneous locomotor activity. These anxiolytic-like effects were blocked by picrotoxin. Results suggest that these fatty acids that are contained in maternal fluid may reduce anxiety-like behavior by modulating GABAergic neurotransmission in infant 28-day-old rats.

4 March 2024 in Journal of Integrative Neuroscience
Verified
Journal Article
Open access
PDF file
GGGabriel Guillén-Ruiz
Gabriel Guillén-Ruiz
BLANDINA BERNAL-MORALESBLANDINA BERNAL-MORALES
BLANDINA BERNAL-MORALES
ALAna Karen Limón-Vázquez
Ana Karen Limón-Vázquez
OOOscar Jerónimo Olmos-Vázquez
Oscar Jerónimo Olmos-Vázquez
JRJuan Francisco Rodríguez-Landa
Juan Francisco Rodríguez-Landa
Background: The flavonoid chrysin produces rapid and long-lasting anxiolytic- and antidepressant-like effects in rats. However, it is not known whether low and high doses of chrysin produce differential anti-immobility effects through the Gamma-Aminobutyric Acid sub-type A (GABAA) receptor. The goal of this work was therefore to compare low and high doses of chrysin for their effects on depression-like behavior in a longitudinal study. Moreover, chrysin was compared with the serotonergic fluoxetine and Gamma-Aminobutyric Acid (GABA)ergic allopregnanolone, and its involvement with the GABAA receptor after chronic treatment was also investigated. Methods: Male Wistar rats were assigned to five groups (n = 8 each): vehicle, 1 mg/kg chrysin, 5 mg/kg chrysin, 1 mg/kg fluoxetine, and 1 mg/kg allopregnanolone. In the first experiment, treatments were injected daily and the effects on locomotor activity and the forced swim test were evaluated at 0, 1, 14, and 28 days of treatment, and 48 h after the final treatment. In the second experiment, similar groups were treated for 28 days with injection of 1 mg/kg picrotoxin to investigate the role of the GABAA receptor. Depending on the experimental design, one- and two-way analysis of variance (ANOVA) tests were used for statistical analysis, with p < 0.05 set as the criteria for significance. Results: In both experiments, the treatments did not alter locomotor activity. However, low and high doses of chrysin, allopregnanolone, and fluoxetine gradually produced antidepressant-like effects in the forced swim test, and maintained this effect for 48 h post-treatment, except with low dose chrysin. Picrotoxin blocked the antidepressant-like effects produced by low dose chrysin, but did not affect those produced by high dose chrysin, allopregnanolone, or fluoxetine. Conclusions: The differential antidepressant-like effects caused by low and high doses of chrysin are time-dependent. Low dose chrysin produces a rapid antidepressant-like effect, whereas high dose chrysin produces a delayed but sustained the effect, even 48 h after withdrawal. The effect with high dose chrysin was similar to that observed with allopregnanolone and fluoxetine. The mechanism for the antidepressant-like effect of low chrysin appears to be GABAergic, whereas the effect of high dose chrysin may involve other neurotransmission and neuromodulation systems related to the serotonergic system.

1 December 2021 in Brain Research Bulletin
Verified
Journal Article
Closed access
ISI. Daniel Salinas-Velarde
I. Daniel Salinas-Velarde
BLANDINA BERNAL-MORALESBLANDINA BERNAL-MORALES
BLANDINA BERNAL-MORALES
PPPablo Pacheco-Cabrera
Pablo Pacheco-Cabrera
PAPedro Sánchez Aparicio
Pedro Sánchez Aparicio
LMLuz Irene Pascual Mathey
Luz Irene Pascual Mathey
AVArturo Venebra-Muñoz
Arturo Venebra-Muñoz

29 March 2016 in American Journal of Psychiatry and Neuroscience
Verified
Journal Article
Open access
PDF file
GGGabriel Guillén-Ruiz
Gabriel Guillén-Ruiz
BLANDINA BERNAL-MORALESBLANDINA BERNAL-MORALES
BLANDINA BERNAL-MORALES
CCCarlos M. Contreras
Carlos M. Contreras
Jonathan Cueto-EscobedoJonathan Cueto-Escobedo
Jonathan Cueto-Escobedo
JRJuan Francisco Rodríguez-Landa
Juan Francisco Rodríguez-Landa
A mixture of eight fatty acids (linoleic, oleic, palmitic, stearic, myristic, elaidic, lauric, and palmitoleic acids) at similar concentrations that have been identified in human amniotic fluid exerts anxiolytic-like effects similar to diazepam in adult Wistar rats through actions at -aminobutyric acid-A (GABA A ) receptors, but unknown is whether any of these fatty acids exerts a predominant action over the others in infant rats. Of these fatty acids, some actions of oleic acid have already been identified, and it is one of the most abundant in amniotic fluid. Therefore, the aim of this study was to explore the effect of oleic acid on anxiety-like behavior and motoric activity in infant rats. To explore sedative actions, 28-day-old Wistar rats received 80-320 µg oleic acid or a sedative dose of diazepam (5 mg/kg). In a dose-response study, other groups of rats were injected with 10-80 µg oleic acid or 1 mg/kg diazepam. In an interaction study, rats that received oleic acid were pretreated with the GABA A receptor antagonists picrotoxin or flumazenil to explore the participation of this receptor in the effects of oleic acid on behavior in the elevated plus maze, rotarod test, and open field test. Oleic acid produced sedative effects but did not exert any anxiolytic-like actions. Hypoactivity and motor incoordination that were induced by oleic acid were blocked by flumazenil and picrotoxin. In conclusion, oleic acid reduced locomotor activity and motor incoordination through actions at the GABA A receptor.